相关实验视频

Updated: Jan 19, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

用工程T细胞向心脏纤维化

Haig Aghajanian^1,2,3, Toru Kimura⁴, Joel G Rurik^1,2,3

¹Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

|September 13, 2019

概括

重定向T细胞免疫疗法有效向小鼠的心脏纤维化. 这种方法可以切除表达特定抗原的心脏纤维细胞,

科学领域:

心脏病学
免疫学
纤维化研究

背景情况:

心脏纤维化,特征是细胞外基质沉积过多,使心脏变硬,功能受损.
它是各种心脏病和心力衰竭的关键因素.
目前针对心脏纤维化的治疗方法有限.

研究的目的:

研究T细胞免疫疗法针对病态心脏纤维化的疗效.
确定和验证这种免疫治疗的特定细胞点.

主要方法:

利用重定向的T细胞免疫疗法向小鼠表达异源抗原的心脏纤维细胞.
对人类心脏中的心脏纤维细胞进行基因表达分析,以确定内源性标.
开发出针对纤维细胞激活蛋白 (FAP) 的仿真抗原受体T细胞.

主要成果:

对抗原特异性CD8+T细胞的采用转移成功地切除了表达异源抗原的心脏纤维细胞.
纤维细胞激活蛋白 (FAP) 被确定为心脏纤维细胞的内源性点.
在小鼠中,针对FAP的化学抗原受体T细胞治疗显著降低了心脏纤维化,并恢复了心脏功能.

结论:

重定向T细胞免疫疗法在向和减少病态心脏纤维化方面表现出有效性.
纤维细胞激活蛋白 (FAP) 是心脏纤维化免疫治疗的可行点.
这项研究为开发心脏病新型免疫疗法提供了原则证明.

更多相关视频

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

Capillary Force Lithography for Cardiac Tissue Engineering

Capillary Force Lithography for Cardiac Tissue Engineering

Published on: June 10, 2014

相关概念视频

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

This manuscript describes the creation of defined engineered cardiac tissues using surface marker expression and cell sorting. The defined tissues can then be used in a multi-tissue bioreactor to investigate mechanisms of cardiac cell therapy in order to provide a functional, yet controlled, model system of the human...

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

We describe the isolation of neonatal cardiomyocytes and the preparation of the cells for encapsulation in fibrin hydrogel constructs for tissue engineering. We describe methods for analyzing the tissue engineered myocardium after the culture period including active force generated upon electrical stimulation and cell viability and immunohistological...

Capillary Force Lithography for Cardiac Tissue Engineering

Capillary Force Lithography for Cardiac Tissue Engineering

In this protocol, we demonstrate the fabrication of biomimetic cardiac cell culture substrata made from two distinct polymeric materials using capillary force lithography. The described methods provide a scalable, cost-effective technique to engineer the structure and function of macroscopic cardiac tissues for in vitro and in vivo...

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

A detailed protocol is provided for using CRISPR/Cas9 technology to achieve highly efficient targeted knock-in of large, multicistronic constructs in primary human T cells via the homology-mediated end joining (HMEJ) DNA repair pathway. T cells engineered with this cGMP-adaptable protocol maintain excellent cell expansion, cytotoxicity, and cytokine...

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

The present protocol generates mesh-shaped engineered cardiac tissues containing cardiovascular cells derived from human induced pluripotent stem cells to allow the investigation of cell implantation therapy for heart...

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

This protocol illustrates a safe and efficient procedure to modify CD133+ hematopoietic stem cells. The presented non-viral, magnetic polyplex-based approach may provide a basis for the optimization of therapeutic stem cell effects as well as for monitoring the administered cell product via magnetic resonance...